2022
DOI: 10.1007/s13042-022-01570-2
|View full text |Cite
|
Sign up to set email alerts
|

A novelty detection approach to effectively predict conversion from mild cognitive impairment to Alzheimer’s disease

Abstract: Accurately recognising patients with progressive mild cognitive impairment (pMCI) who will develop Alzheimer’s disease (AD) in subsequent years is very important, as early identification of those patients will enable interventions to potentially reduce the number of those transitioning from MCI to AD. Most studies in this area have concentrated on high-dimensional neuroimaging data with supervised binary/multi-class classification algorithms. However, neuroimaging data is more costly to obtain than non-imaging… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 76 publications
0
2
0
Order By: Relevance
“…To obtain results, in most cases researchers exploited the predictive capabilities of standard Machine Learning (ML) methods together with a mere statistical analysis of the data at different time scans. As an example, both in [16,21] and in [6,22] the authors used Support Vector Machine (SVM) applied to brain network graphs to detect MCI-to-AD subjects using features computed from local and global graph measures, with high percentages of accuracy, sensitivity, and specificity. On the other hand, we can say that the difference in percentage can also occur when a different cohort of patients and methodology are used: in [20], the authors investigate whether the combination of fluoro-2deoxy-d-glucose and PET measures with the APOE genotype would improve prediction of the MCI-to-AD conversion.…”
Section: Backgrounds and Motivationsmentioning
confidence: 99%
“…To obtain results, in most cases researchers exploited the predictive capabilities of standard Machine Learning (ML) methods together with a mere statistical analysis of the data at different time scans. As an example, both in [16,21] and in [6,22] the authors used Support Vector Machine (SVM) applied to brain network graphs to detect MCI-to-AD subjects using features computed from local and global graph measures, with high percentages of accuracy, sensitivity, and specificity. On the other hand, we can say that the difference in percentage can also occur when a different cohort of patients and methodology are used: in [20], the authors investigate whether the combination of fluoro-2deoxy-d-glucose and PET measures with the APOE genotype would improve prediction of the MCI-to-AD conversion.…”
Section: Backgrounds and Motivationsmentioning
confidence: 99%
“…Machine learning-based diagnostic decision systems held significant potential for generating substantial economic benefits. However, training machine learning algorithms [10] for clinical applications often posed challenges. Firstly, imbalanced data distributions might lead to inflated performance estimates for traditional binary/multiclass classifiers [11] .…”
Section: Introductionmentioning
confidence: 99%